Clinical Trials Directory

Trials / Completed

CompletedNCT02252159

Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)

Prospective, Non-interventional Study of Disease Progression and Treatment of Patients With Polycythemia Vera in United States Academic or Community Clinical Practices

Status
Completed
Phase
Study type
Observational
Enrollment
2,544 (actual)
Sponsor
Incyte Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a Phase IV, multicenter, non-interventional, non-randomized, prospective, observational study in an adult population (patients \>18 years old) of men and women who have been diagnosed with clinically overt PV and are being followed in either community or academic medical centers in the United States who will be enrolled over a 12-month period and observed for 36 months from the date the last patient is enrolled.

Conditions

Timeline

Start date
2014-07-31
Primary completion
2019-08-03
Completion
2019-08-03
First posted
2014-09-30
Last updated
2021-04-26

Locations

266 sites across 2 countries: United States, Puerto Rico

Source: ClinicalTrials.gov record NCT02252159. Inclusion in this directory is not an endorsement.

Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL) (NCT02252159) · Clinical Trials Directory